Deutsche Bank Ag\ Biotechnology

Deutsche Bank Ag\

$245 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
TNGX Tango Therapeutics, Inc.	$604M	$73,000 0.0% of portfolio	53,788	Q4 2024 Reduced 31.86%
TCRX T Scan Therapeutics, Inc.	$35.6M	$72,000 0.0% of portfolio	52,559	Q4 2024 Reduced 59.9%
TNYA Tenaya Therapeutics, Inc.	$36M	$70,000 0.0% of portfolio	123,197	Q4 2024 Added 4.97%
PEPG Pep Gen Inc.	$28.8M	$68,000 0.0% of portfolio	48,518	Q4 2024 Reduced 7.8%
THRD Third Harmonic Bio, Inc.	$219M	$68,000 0.0% of portfolio	19,815	Q4 2024 Reduced 1.4%
ZNTL Zentalis Pharmaceuticals, Inc.	$82.1M	$68,000 0.0% of portfolio	42,804	Q3 2024 Reduced 25.4%
MGNX Macrogenics Inc	$94.6M	$64,000 0.0% of portfolio	51,093	Q4 2024 Reduced 97.44%
PLRX Pliant Therapeutics, Inc.	$69.1M	$64,000 0.0% of portfolio	47,472	Q4 2024 Added 5,275.52%
XFOR X4 Pharmaceuticals, Inc	$99.5M	$64,000 0.0% of portfolio	267,628	Q3 2024 Reduced 84.84%
ALXO Alx Oncology Holdings Inc	$20M	$62,000 0.0% of portfolio	101,113	Q3 2024 Reduced 83.9%
PRLD Prelude Therapeutics Inc	$29.8M	$62,000 0.0% of portfolio	80,723	Q4 2024 Added 53.49%
NKTR Nektar Therapeutics	$5B	$60,000 0.0% of portfolio	88,549	Q3 2024 New
RLMD Relmada Therapeutics, Inc.	$17.2M	$60,000 0.0% of portfolio	224,846	Q4 2023 Added 4,434.1%
BCYC Bicycle Therapeutics PLC	$239M	$54,000 0.0% of portfolio	6,417	Q3 2024 Added 25.76%
IGMS Igm Biosciences, Inc.	$36.8M	$53,000 0.0% of portfolio	46,773	Q4 2024 Reduced 76.0%
SAVA Cassava Sciences Inc	$84.2M	$51,000 0.0% of portfolio	34,615	Q4 2024 Added 5.65%
ELEV Elevation Oncology, Inc.	$8.62M	$48,000 0.0% of portfolio	185,578	Q4 2024 Added 1.72%
NAUT Nautilus Biotechnology, Inc.	$91M	$47,000 0.0% of portfolio	54,839	Q4 2024 Reduced 59.21%
IPSC Century Therapeutics, Inc.	$34.2M	$46,000 0.0% of portfolio	96,140	Q4 2024 Added 101.13%
CRBU Caribou Biosciences, Inc.	$111M	$45,000 0.0% of portfolio	49,576	Q2 2024 Reduced 39.53%
LYEL Lyell Immunopharma, Inc.	$2.36B	$44,000 0.0% of portfolio	82,441	Q2 2024 Reduced 29.26%
GBIO Generation Bio Co.	$30.7M	$43,000 0.0% of portfolio	108,771	Q4 2024 Added 69.32%
LXRX Lexicon Pharmaceuticals, Inc.	$255M	$43,000 0.0% of portfolio	94,394	Q4 2024 Added 234.41%
INZY Inozyme Pharma, Inc.	$161M	$36,000 0.0% of portfolio	40,215	Q3 2024 Reduced 22.52%
MLTX Moon Lake Immunotherapeutics	$1.81B	$35,000 0.0% of portfolio	903	Q3 2024 Reduced 37.43%
BDTX Black Diamond Therapeutics, Inc.	$118M	$34,000 0.0% of portfolio	22,388	Q2 2024 New
VTYX Ventyx Biosciences, Inc.	$185M	$34,000 0.0% of portfolio	30,328	Q2 2024 Reduced 41.56%
OVID Ovid Therapeutics Inc.	$33.8M	$32,000 0.0% of portfolio	105,177	Q1 2024 Reduced 77.2%
CABA Cabaletta Bio, Inc.	$49.3M	$31,000 0.0% of portfolio	22,361	Q2 2024 Reduced 37.31%
PYXS Pyxis Oncology, Inc.	$41.8M	$27,000 0.0% of portfolio	28,390	Q4 2024 Added 6.73%
AVTE Aerovate Therapeutics, Inc.	$65.5M	$12,000 0.0% of portfolio	4,872	Q4 2024 Reduced 85.22%
ZLAB Zai Lab LTD	$3.53B	$5,000 0.0% of portfolio	159	Q4 2024 Added 108.81%
VRCA Verrica Pharmaceuticals Inc.	$327M	$4,000 0.0% of portfolio	591	Q2 2024 Added 30,698.65%
RGLS Regulus Therapeutics Inc.	$119M	$3,000 0.0% of portfolio	2,252	Q1 2025 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	39,103	Q4 2024 Added 10.93%
IFRX Infla Rx N.V.	$38.5M	$0 0.0% of portfolio	200	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.